Lars Lange
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lars Lange has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
- Margitta Worm
Division of Allergy and Immunology, Department of Dermatology, Venereology and Allergy Charité—University Medical Center Berlin, Corporate Member of Freie Universität Berlin and Humboldt‐Universität Zu Berlin Berlin Germany
8 shared publications - Sabine Dölle
Division of Allergy and Immunology, Department of Dermatology, Venereology and Allergy Charité—University Medical Center Berlin, Corporate Member of Freie Universität Berlin and Humboldt‐Universität Zu Berlin Berlin Germany
5 shared publications - Franziska Ruëff
LMU Munich
3 shared publications - Karin Hartmann
Divison of Allergy, Department of Dermatology University Hospital Basel and University of Basel Basel Switzerland
3 shared publications - Maria Beatrice Bilò
Department of Clinical and Molecular Sciences Università Politecnica delle Marche Ancona Italy
3 shared publications - Nikolaos G. Papadopoulos
Allergy Department Second Pediatric Clinic, National and Kapodistrian University of Athens, Greece
3 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by MDPI AG in Preprints.org
Hymenoptera Venom Allergy in Children and Adolescents: Clinical Features, Sensitization Patterns, and Outcomes of Venom Immunotherapy — A Ten-Year Retrospective Single-Center Study
Background: Hymenoptera venom allergy is an important cause of anaphylaxis in children and adolescents, yet pediatric-specific data on sensitization patterns and their clinical relevance remain limited as are long-term data after venom immunotherapy (VIT). Objective: To characterize the clinical presentation, sensitization profile, and outcome of VIT in children and adolescents with Hymenoptera venom allergy. Methods: In this retrospective single-center study, 170 children and adolescents (0–18 years) who presented with a suspected sting-induced allergic reaction at a pediatric university hospital between 2013 and 2023 were identified. Seventy-three patients had confirmed venom allergy and initiated VIT; 44 returned a standardized follow-up questionnaire capturing symptoms at the index reaction, VIT tolerability, and outcome after field re-stings. Results: Yellow jacket and honeybee accounted for all confirmed cases. Cutaneous symptoms were the major findings at the index reaction (97.7%). Grade II reactions predominated (70.5%); grade IV reactions were absent. Baseline tryptase was within the normal range in the large majority of patients and showed no relationship with reaction severity. Component-resolved diagnostics confirmed Api m 1/Api m 10 and Ves v 1/Ves v 5 as the most frequently positive marker allergens, but sensitization patterns were not consistently associated with reaction severity. VIT was well tolerated, with a marked reduction in symptom frequency across all organ systems during therapy. Among 17 patients with a documented field re-sting, symptoms were substantially reduced compared with the index reaction but not eliminated. No severe reactions occurred after field stings. Adrenaline was used in only 15.9% of index reactions, and criteria for emergency kit discontinuation after VIT were applied inconsistently. Conclusions: Pediatric hymenoptera venom allergy is a distinct clinical entity in which classical adult risk factors and molecular sensitization profiles have limited prognostic value. VIT is safe and substantially reduces reactions risk after re-sting, supporting continued emergency preparedness and individualized, rather than time-based, emergency kit discontinuation.
- 18 November 2026
- Published by MDPI AG in Preprints.org
Open AccessHymenoptera Venom Allergy in Children and Adolescents: Clinical Features, Sensitization Patterns, and Outcomes of Venom Immunotherapy — A Ten-Year Retrospective Single-Center Study
Background: Hymenoptera venom allergy is an important cause of anaphylaxis in children and adolescents, yet pediatric-specific data on sensitization patterns and their clinical relevance remain limited as are long-term data after venom immunotherapy (VIT). Objective: To characterize the clinical presentation, sensitization profile, and outcome of VIT in children and adolescents with Hymenoptera venom allergy. Methods: In this retrospective single-center study, 170 children and adolescents (0–18 years) who presented with a suspected sting-induced allergic reaction at a pediatric university hospital between 2013 and 2023 were identified. Seventy-three patients had confirmed venom allergy and initiated VIT; 44 returned a standardized follow-up questionnaire capturing symptoms at the index reaction, VIT tolerability, and outcome after field re-stings. Results: Yellow jacket and honeybee accounted for all confirmed cases. Cutaneous symptoms were the major findings at the index reaction (97.7%). Grade II reactions predominated (70.5%); grade IV reactions were absent. Baseline tryptase was within the normal range in the large majority of patients and showed no relationship with reaction severity. Component-resolved diagnostics confirmed Api m 1/Api m 10 and Ves v 1/Ves v 5 as the most frequently positive marker allergens, but sensitization patterns were not consistently associated with reaction severity. VIT was well tolerated, with a marked reduction in symptom frequency across all organ systems during therapy. Among 17 patients with a documented field re-sting, symptoms were substantially reduced compared with the index reaction but not eliminated. No severe reactions occurred after field stings. Adrenaline was used in only 15.9% of index reactions, and criteria for emergency kit discontinuation after VIT were applied inconsistently. Conclusions: Pediatric hymenoptera venom allergy is a distinct clinical entity in which classical adult risk factors and molecular sensitization profiles have limited prognostic value. VIT is safe and substantially reduces reactions risk after re-sting, supporting continued emergency preparedness and individualized, rather than time-based, emergency kit discontinuation.
- Open Access
- 23 October 2026
- Published by Wiley in Clinical & Experimental Allergy
Cofactors in Anaphylaxis: Insights From the European Anaphylaxis Registry
Background: The role of cofactors contributing to anaphylaxis severity remains unclear. Methods: We analysed data from the European Anaphylaxis Registry (2007–2024) to determine the impact of suspected cofactors on reaction severity. Adjusted odds ratios (aOR) were calculated for the number of organ systems affected, but also two severity classification systems (Ring/Messmer and Brown). Results: At least one suspected cofactor was reported in 8310 cases (49%) out of 16,915. Cofactors were less frequently suspected among younger patients (< 18 years: 26% and ≥ 18 years: 59%). Medication was the most common suspected cofactor in adults (41%), followed by exercise (27%), which was in parallel the most frequent suspected cofactor in children (19%). Emotional burden (children 3%/adults 8%), alcohol (0.4%/8%), sleep deprivation (0.5%/2%) and menstruation (2%/4%) were less commonly reported. We observed a trend between reaction severity and an increasing number of suspected cofactors. Among suspected cofactors, we observed consistent effects on anaphylaxis reaction severity for acute infections among children and alcohol consumption among adults in food‐induced reactions. Moreover, we identified an association between the presence of a suspected cofactor(s) and an increased time interval between exposure and onset of symptoms across all age groups in food‐induced anaphylaxis. Conclusions: Our data suggest an age‐dependent role of suspected cofactors in anaphylaxis severity. Clinicians should explore the presence of cofactors in patients who experienced anaphylaxis, in particular in those with prolonged time intervals between exposure and reaction onset.
- 23 October 2026
- Published by Wiley in Clinical & Experimental Allergy
Open AccessCofactors in Anaphylaxis: Insights From the European Anaphylaxis Registry
Background: The role of cofactors contributing to anaphylaxis severity remains unclear. Methods: We analysed data from the European Anaphylaxis Registry (2007–2024) to determine the impact of suspected cofactors on reaction severity. Adjusted odds ratios (aOR) were calculated for the number of organ systems affected, but also two severity classification systems (Ring/Messmer and Brown). Results: At least one suspected cofactor was reported in 8310 cases (49%) out of 16,915. Cofactors were less frequently suspected among younger patients (< 18 years: 26% and ≥ 18 years: 59%). Medication was the most common suspected cofactor in adults (41%), followed by exercise (27%), which was in parallel the most frequent suspected cofactor in children (19%). Emotional burden (children 3%/adults 8%), alcohol (0.4%/8%), sleep deprivation (0.5%/2%) and menstruation (2%/4%) were less commonly reported. We observed a trend between reaction severity and an increasing number of suspected cofactors. Among suspected cofactors, we observed consistent effects on anaphylaxis reaction severity for acute infections among children and alcohol consumption among adults in food‐induced reactions. Moreover, we identified an association between the presence of a suspected cofactor(s) and an increased time interval between exposure and onset of symptoms across all age groups in food‐induced anaphylaxis. Conclusions: Our data suggest an age‐dependent role of suspected cofactors in anaphylaxis severity. Clinicians should explore the presence of cofactors in patients who experienced anaphylaxis, in particular in those with prolonged time intervals between exposure and reaction onset.
- Open Access
Frequency and Severity of Allergic Reactions to Non‐Mandatory Labelled Allergenic Foods—Data From Two Large European Cohorts
Background: The consumption of plant‐based food has lately largely increased, raising concerns about allergic reactions from ingredients which are currently not subject to mandatory labelling. Methods: We analysed the frequency and severity of allergic reactions to non‐mandatory labelled allergenic foods (pea, lentil, bean, chickpea, fenugreek, pine nut, sunflower‐, poppy‐, pumpkin seed, buckwheat) from two large European cohorts: The Anaphylaxis Registry (NORA) and EuroPrevall outpatient clinic study. Severity was assessed using the Food Allergy Severity Score (FASS) and compared with reactions to mandatory labelled allergenic foods. Results: Among 589 reactions from both cohorts, sunflower seed was the most frequent trigger ( n = 126). In NORA, pine nut (1.0% of food‐induced allergic reactions) was most common followed by pea and buckwheat (0.7% each); in EuroPrevall, sunflower seed (1.2%), poppy seed (0.6%) and lentil (0.6%) predominated. After adjusting for age and sex, the severity of reactions to mandatory labelled seeds and legumes (excluding peanut) were not different (nFASS median: 4.39 vs. 4.43 and 4.56 vs. 4.49). Whereas, cereal‐induced reactions (6.47) were significantly more severe than buckwheat (4.77). In Nora, the number of reactions to fenugreek and pumpkin seed were 7.4‐ and 3.7‐fold higher in 2015–2022 versus 2007–2014. Conclusion: Non‐mandatory labelled allergenic foods were identified to cause severe allergic reactions in two large European cohorts. The frequent involvement of sunflower seed, pine nut, pea and lentil, but also rising numbers of reactions to fenugreek and pumpkin seed, indicates their potential risk. These allergenic foods warrant close monitoring and consideration in future allergen labelling revisions.
Open AccessFrequency and Severity of Allergic Reactions to Non‐Mandatory Labelled Allergenic Foods—Data From Two Large European Cohorts
Background: The consumption of plant‐based food has lately largely increased, raising concerns about allergic reactions from ingredients which are currently not subject to mandatory labelling. Methods: We analysed the frequency and severity of allergic reactions to non‐mandatory labelled allergenic foods (pea, lentil, bean, chickpea, fenugreek, pine nut, sunflower‐, poppy‐, pumpkin seed, buckwheat) from two large European cohorts: The Anaphylaxis Registry (NORA) and EuroPrevall outpatient clinic study. Severity was assessed using the Food Allergy Severity Score (FASS) and compared with reactions to mandatory labelled allergenic foods. Results: Among 589 reactions from both cohorts, sunflower seed was the most frequent trigger ( n = 126). In NORA, pine nut (1.0% of food‐induced allergic reactions) was most common followed by pea and buckwheat (0.7% each); in EuroPrevall, sunflower seed (1.2%), poppy seed (0.6%) and lentil (0.6%) predominated. After adjusting for age and sex, the severity of reactions to mandatory labelled seeds and legumes (excluding peanut) were not different (nFASS median: 4.39 vs. 4.43 and 4.56 vs. 4.49). Whereas, cereal‐induced reactions (6.47) were significantly more severe than buckwheat (4.77). In Nora, the number of reactions to fenugreek and pumpkin seed were 7.4‐ and 3.7‐fold higher in 2015–2022 versus 2007–2014. Conclusion: Non‐mandatory labelled allergenic foods were identified to cause severe allergic reactions in two large European cohorts. The frequent involvement of sunflower seed, pine nut, pea and lentil, but also rising numbers of reactions to fenugreek and pumpkin seed, indicates their potential risk. These allergenic foods warrant close monitoring and consideration in future allergen labelling revisions.
- 26 June 2025
- Published by Springer Nature in Allergo Journal International
- Vol. 34 (5) , 127-133
Diagnosis of food allergies
- 26 June 2025
- Published by Springer Nature in Allergo Journal International
- Vol. 34 (5) , 127-133
Diagnosis of food allergies
- Open Access
A Growing Concern for Cashew and an Unexpected Risk From Almonds: Data From the Anaphylaxis Registry
Background: Food allergies are a major health concern with rising prevalence. Dietary habits are changing, and information about cashew‐induced anaphylaxis is limited.Methods: Cases of tree nut‐induced anaphylaxis (TIA) registered from 2007 until April 2024 were extracted from the European Anaphylaxis Registry and analyzed.Results: 1389 cases of TIA out of 5945 registered food‐induced reactions (23%) were identified. 1,083 cases with confirmed elicitor status, including 845 children (median age 4 years, 61% male) and 238 adults (38 years, 40% male), were selected for further analysis. The most frequent elicitors among children were cashew (n = 334), hazelnut (n = 211) and walnut (n = 146). The proportion of cashew‐induced anaphylaxis increased from 2007 to 2024, and reactions were frequently caused by small amounts (< 1 teaspoon). Adults reacted frequently to hazelnut (n = 105), walnut (n = 47) but also almond (n = 35) and to higher amounts. Potential cofactors were present in 50% of the adult patients and 17% of children. The reaction severity was age‐independent, and only a minority of patients was previously aware of their allergy (children 23%, adults 21%). The use of adrenaline was low in lay treatment (children 13%, adults 3%) and reached approximately 40% upon professional treatment.Conclusion: Cashew is an increasing, relevant allergen leading to anaphylaxis and is now the most frequent cause of TIA among children. These findings highlight the need for effective prevention and treatment measures. Almond was a frequent elicitor among adults and should be further monitored. The acute management requires improvement to comply with current guidelines.
Open AccessA Growing Concern for Cashew and an Unexpected Risk From Almonds: Data From the Anaphylaxis Registry
Background: Food allergies are a major health concern with rising prevalence. Dietary habits are changing, and information about cashew‐induced anaphylaxis is limited.Methods: Cases of tree nut‐induced anaphylaxis (TIA) registered from 2007 until April 2024 were extracted from the European Anaphylaxis Registry and analyzed.Results: 1389 cases of TIA out of 5945 registered food‐induced reactions (23%) were identified. 1,083 cases with confirmed elicitor status, including 845 children (median age 4 years, 61% male) and 238 adults (38 years, 40% male), were selected for further analysis. The most frequent elicitors among children were cashew (n = 334), hazelnut (n = 211) and walnut (n = 146). The proportion of cashew‐induced anaphylaxis increased from 2007 to 2024, and reactions were frequently caused by small amounts (< 1 teaspoon). Adults reacted frequently to hazelnut (n = 105), walnut (n = 47) but also almond (n = 35) and to higher amounts. Potential cofactors were present in 50% of the adult patients and 17% of children. The reaction severity was age‐independent, and only a minority of patients was previously aware of their allergy (children 23%, adults 21%). The use of adrenaline was low in lay treatment (children 13%, adults 3%) and reached approximately 40% upon professional treatment.Conclusion: Cashew is an increasing, relevant allergen leading to anaphylaxis and is now the most frequent cause of TIA among children. These findings highlight the need for effective prevention and treatment measures. Almond was a frequent elicitor among adults and should be further monitored. The acute management requires improvement to comply with current guidelines.
- 10 June 2024
- Published by Georg Thieme Verlag KG in Kinder- und Jugendmedizin
- Vol. 24 (03) , 189-196
Tierallergie
ZUSAMMENFASSUNG: Tierallergien sind ein häufiges und relevantes Thema in der allergologischen Praxis. 69 % der deutschen Haushalte mit Kindern besitzen ein Haustier. Fast 13 % aller Kinder sind gegen Haustiere sensibilisiert. Viele dieser Sensibilisierungen sind jedoch klinisch nicht relevant. Durch eine gute Anamnese und mithilfe moderner diagnostischer Methoden ist es möglich, das auslösende Tier genauer zu identifizieren und die Relevanz zu klären. Klare und differenzierte Meidungsempfehlungen können die Allergenlast in der Umgebung der Patienten senken.Leider sind viele Fragen zur Tierallergie offen und etablierte Therapieempfehlungen fehlen. In diesem Artikel werden verschiedene Optionen zur Diagnostik und Therapie vorgestellt.
- 10 June 2024
- Published by Georg Thieme Verlag KG in Kinder- und Jugendmedizin
- Vol. 24 (03) , 189-196
Tierallergie
ZUSAMMENFASSUNG: Tierallergien sind ein häufiges und relevantes Thema in der allergologischen Praxis. 69 % der deutschen Haushalte mit Kindern besitzen ein Haustier. Fast 13 % aller Kinder sind gegen Haustiere sensibilisiert. Viele dieser Sensibilisierungen sind jedoch klinisch nicht relevant. Durch eine gute Anamnese und mithilfe moderner diagnostischer Methoden ist es möglich, das auslösende Tier genauer zu identifizieren und die Relevanz zu klären. Klare und differenzierte Meidungsempfehlungen können die Allergenlast in der Umgebung der Patienten senken.Leider sind viele Fragen zur Tierallergie offen und etablierte Therapieempfehlungen fehlen. In diesem Artikel werden verschiedene Optionen zur Diagnostik und Therapie vorgestellt.
- 1 October 2023
- Published by Dustri-Verlag Dr. Karl Feistle in Allergologie select
- Vol. 46 (10) , 649-689
Diagnose und Therapie der Bienen- und Wespengiftallergie
- 1 October 2023
- Published by Dustri-Verlag Dr. Karl Feistle in Allergologie select
- Vol. 46 (10) , 649-689
Diagnose und Therapie der Bienen- und Wespengiftallergie
- 13 September 2023
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 174 (S4) , 1
Erratum zu: Nahrungsmittelproteininduzierte allergische Säuglingskolitis und nahrungsmittelproteininduziertes Enterokolitissyndrom
- 13 September 2023
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 174 (S4) , 1
Erratum zu: Nahrungsmittelproteininduzierte allergische Säuglingskolitis und nahrungsmittelproteininduziertes Enterokolitissyndrom
- 15 June 2023
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 171 (8) , 743-753
Nahrungsmittelproteininduzierte allergische Säuglingskolitis und nahrungsmittelproteininduziertes Enterokolitissyndrom
- 15 June 2023
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 171 (8) , 743-753
Nahrungsmittelproteininduzierte allergische Säuglingskolitis und nahrungsmittelproteininduziertes Enterokolitissyndrom
- 1 April 2022
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 10 (4) , 1063-1069
Different Patterns of Foods Triggering FPIES in Germany
- 1 April 2022
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 10 (4) , 1063-1069
Different Patterns of Foods Triggering FPIES in Germany